Read the Wikipedia article on him. He is a primarily a stock manipulator who specializes in biotech stocks. Before his drug pricing hijinks he started and shu

Read the Wikipedia article on him. He is a primarily a stock manipulator who specializes in biotech stocks. Before his drug pricing hijinks he started and shuttered to hedge funds, both of which failed owing millions of dollars to cover trades they had made. He is about as knowledgable about pharmaceuticals as a third tier equity analyst. He's not a researcher -- his degree is in business. (Don't get me wrong -- I have no love for the pharmaceutical industry. But this guy is nothing more than a promoter.)